Citius Pharmaceuticals Inc (CTXR) Stock Price Today
Aura AI Summary
Key Stats
- $10.86MMarket Cap
- 383,635Volume
- HealthSector
- $1.8252W High
- $0.4052W Low
- 18 DaysTypical Hold Time
- $1.03MEnterprise Value
- -Div Yield
- 0% Sell | 100% BuyTrading Activity
Track Citius Pharmaceuticals Inc (CTXR) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Citius Pharmaceuticals Inc has traded between a low of $0.37 and a high of $1.82, highlighting its annual price range. Buy and sell Citius Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Most Recent News
Aduro Clean Technologies to present advances and engage investors at five key industry conferences through end of 2026
Aduro Clean Technologies announced its participation in five major industry and investor conferences from October to December 2026. The company will showcase progress in its Hydrochemolytic™ technology for recycling plastics and upgrading crude oils,...

Aduro Clean Technologies to present at five industry and investor conferences by end of 2026
Aduro Clean Technologies announced it will participate in five conferences between October and December 2026, engaging with industry professionals and institutional investors. Key topics include updates on their Hydrochemolytic™ technology for recycl...

Remittix nears $36M cap as Cardano's new language sparks $2 ADA forecast, BNB eyes $1,500
Remittix has raised $33 million in its presale, nearing its $36 million hard cap ahead of its November 24, 2026 launch. The project offers a PayFi ecosystem connecting crypto with bank payments, with active product use and testing underway. Meanwhile...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.